ATE518142T1 - Adam12 als marker für das turner-syndrom beim fötus - Google Patents

Adam12 als marker für das turner-syndrom beim fötus

Info

Publication number
ATE518142T1
ATE518142T1 AT07122125T AT07122125T ATE518142T1 AT E518142 T1 ATE518142 T1 AT E518142T1 AT 07122125 T AT07122125 T AT 07122125T AT 07122125 T AT07122125 T AT 07122125T AT E518142 T1 ATE518142 T1 AT E518142T1
Authority
AT
Austria
Prior art keywords
adam12
turner
fetus
syndrome
marker
Prior art date
Application number
AT07122125T
Other languages
English (en)
Inventor
Ulla M Wewer
Michael Christiansen
Camilla Froelich
Jennie Laigaard
Bent Norgaard-Pedersen
Kevin Spencer
Original Assignee
Uinv Kobenhavns
Statens Seruminstitut
Harold Wood Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uinv Kobenhavns, Statens Seruminstitut, Harold Wood Hospital filed Critical Uinv Kobenhavns
Application granted granted Critical
Publication of ATE518142T1 publication Critical patent/ATE518142T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4745—Insulin-like growth factor binding protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT07122125T 2004-05-19 2005-05-18 Adam12 als marker für das turner-syndrom beim fötus ATE518142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57251904P 2004-05-19 2004-05-19

Publications (1)

Publication Number Publication Date
ATE518142T1 true ATE518142T1 (de) 2011-08-15

Family

ID=34956324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07122125T ATE518142T1 (de) 2004-05-19 2005-05-18 Adam12 als marker für das turner-syndrom beim fötus

Country Status (11)

Country Link
US (3) US7678544B2 (de)
EP (3) EP1687640A2 (de)
CN (1) CN1981196B (de)
AR (1) AR049279A1 (de)
AT (1) ATE518142T1 (de)
AU (1) AU2005243064A1 (de)
BR (1) BRPI0511435A (de)
CA (1) CA2508779A1 (de)
DE (1) DE05739600T1 (de)
MX (1) MXPA06013470A (de)
WO (1) WO2005111626A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1524523A1 (de) * 2003-10-17 2005-04-20 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Verwendung von ADAM 12 zur Diagnose und Behandlung von Preeclampsia
CA3007182A1 (en) * 2005-03-18 2006-09-21 The Chinese University Of Hong Kong Markers for prenatal diagnosis, monitoring or predicting preeclampsia
AU2007210124A1 (en) * 2006-01-26 2007-08-09 The Trustees Of The University Of Pennsylvania Tumor vasculature markers and methods of use thereof
WO2008119882A2 (en) * 2007-03-30 2008-10-09 Wallac Oy Screening methods based on human adam12 polypeptide and binding agents thereof
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
CN107677828A (zh) * 2008-10-31 2018-02-09 耶鲁大学 子痫前期检测和治疗的方法和组合物
US20110251094A1 (en) 2010-04-13 2011-10-13 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2596132A4 (de) 2010-07-23 2013-12-18 Harvard College Verfahren zur erkennung von anzeichen für krankheiten oder leiden in körperflüssigkeiten
US20120142559A1 (en) * 2010-12-06 2012-06-07 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
US8703128B2 (en) 2011-01-24 2014-04-22 New York University Methods of modulating TGFβ signaling
EP2726631A1 (de) 2011-06-28 2014-05-07 Vitateq Biotechnology GmbH Verfahren zur diagnose von präeklampsie
EP2766726A1 (de) * 2011-10-14 2014-08-20 Aarhus Universitet Diagnostischr und prognostische verwendung von prombp-komplexen
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
CN103105384A (zh) * 2012-09-20 2013-05-15 河南生生医疗器械有限公司 一种时间分辨荧光法综合检测乳腺癌试剂盒及其应用
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
CA2907120C (en) * 2013-03-15 2023-10-17 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
WO2016001613A1 (en) * 2014-07-02 2016-01-07 Map Diagnostics Limited Methods of detecting ectopic pregnancy
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
KR20180029046A (ko) * 2015-06-19 2018-03-19 세라 프로그노스틱스 인코포레이티드 조산 예측용 바이오마커 쌍
WO2018076134A1 (en) * 2016-10-24 2018-05-03 Ldx Prognostics Limited Co. Methods and kits for providing a preeclampsia assessment and prognosing preterm birth
CN106771265A (zh) * 2017-01-12 2017-05-31 广州市丰华生物工程有限公司 生长激素定量检测试剂盒及其制备方法
CN109726391B (zh) * 2018-12-11 2024-01-09 中科恒运股份有限公司 对文本进行情感分类的方法、装置及终端
CN111047577B (zh) * 2019-12-12 2021-02-26 太原理工大学 一种畸形尿红细胞分类统计方法与系统
CN114958758B (zh) * 2021-02-18 2024-04-23 南京启真基因工程有限公司 一种乳腺癌模型猪的构建方法及应用
CN117954083B (zh) * 2023-03-01 2024-07-05 暨南大学附属第一医院（广州华侨医院） 一种基于机器学习算法的子痫前期预测方法
CN118178615B (zh) * 2024-03-27 2024-12-17 南方医科大学 趋化因子xcl1在制备抗高龄孕妇晚期不良妊娠结局药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1364772A (zh) * 2001-01-10 2002-08-21 上海博德基因开发有限公司 一种新的多肽——人驱动蛋白轻链 14.74和编码这种多肽的多核苷酸
AU2003226955A1 (en) * 2002-04-19 2003-11-03 Bioimage A/S Translocation dependent complementation for drug screening
EP1524523A1 (de) * 2003-10-17 2005-04-20 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Verwendung von ADAM 12 zur Diagnose und Behandlung von Preeclampsia

Also Published As

Publication number Publication date
DE05739600T1 (de) 2006-12-28
CA2508779A1 (en) 2005-11-19
BRPI0511435A (pt) 2007-12-26
AR049279A1 (es) 2006-07-12
EP1901074B1 (de) 2011-07-27
EP1687640A2 (de) 2006-08-09
US8114609B2 (en) 2012-02-14
MXPA06013470A (es) 2008-03-13
CN1981196B (zh) 2012-10-03
WO2005111626A3 (en) 2005-12-29
US7678544B2 (en) 2010-03-16
US20060134654A1 (en) 2006-06-22
EP1901074A1 (de) 2008-03-19
AU2005243064A1 (en) 2005-11-24
US20100190174A1 (en) 2010-07-29
US20120149040A1 (en) 2012-06-14
CN1981196A (zh) 2007-06-13
EP2175277A1 (de) 2010-04-14
EP2175277B1 (de) 2013-09-04
WO2005111626A2 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
ATE518142T1 (de) Adam12 als marker für das turner-syndrom beim fötus
EG24656A (en) On line off line scoring bridge
DK1761533T3 (da) 1-Aza-bicyclo[3.3.1]nonaner
GB0519690D0 (en) Work linkage position determining system
DE112004000857D2 (de) Eisen-Chrom-Aluminium-Legierung
EP1829267A4 (de) Redundante l2tp-endpunkte
FR2869279B1 (fr) Balai d'essuie-glace
GB0322246D0 (en) Improvement in or relating to isobutylene
FI20041641L (fi) Sovitelma silmänpainemittarissa
PL1651770T3 (pl) Cząsteczki promotorowe do zastosowania w roślinach
ATA14952002A (de) Hyraulische betätigungsanordnung
DE602004021019D1 (de) Scheibensägenblatt
FR2867125B1 (fr) Balai d'essuie-glace
ITPR20040020A1 (it) Attrezzo da palestra per traslare l'appoggio rovesciato.
FR2868377B1 (fr) Balai d'essuie-glace
FI20050916A0 (fi) Järjestely lastuavassa työkalussa
GB2423113B (en) The scoot along working platform
GB0411644D0 (en) The reading ruler
ITVR20040012A1 (it) Procedimento per l'ottenimento di lastre in gomma ad effetto pull-up.
AU2752P (en) WINDSOR Lilium hybrid
FR2886252B1 (fr) Balai d'essuie-glace
FI20040257A0 (fi) Parannus puoliperävaunujärjestelmässä
GB0624137D0 (en) HGV finger print strips + ball 1 side L & R
ITVI20050260A1 (it) Dispositivo manuale, particolarmente adatto per l'applicazione al tritacarne, per la formazione di hamburger
ITRM20040388A1 (it) Pipino l'appaiacalzino

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties